Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3264940
Max Phase: Preclinical
Molecular Formula: C14H11F3O5S
Molecular Weight: 348.30
Molecule Type: Small molecule
Associated Items:
ID: ALA3264940
Max Phase: Preclinical
Molecular Formula: C14H11F3O5S
Molecular Weight: 348.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC12COS(=O)(=O)CC1=C(c1ccc(C(F)(F)F)cc1)C(=O)O2
Standard InChI: InChI=1S/C14H11F3O5S/c1-13-7-21-23(19,20)6-10(13)11(12(18)22-13)8-2-4-9(5-3-8)14(15,16)17/h2-5H,6-7H2,1H3
Standard InChI Key: CKKKBOVQQKRFPT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 348.30 | Molecular Weight (Monoisotopic): 348.0279 | AlogP: 2.13 | #Rotatable Bonds: 1 |
Polar Surface Area: 69.67 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.30 | CX LogD: 2.30 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.57 | Np Likeness Score: 0.12 |
1. Xu HW, Zhao LJ, Liu HF, Zhao D, Luo J, Xie XP, Liu WS, Zheng JX, Dai GF, Liu HM, Liu LH, Liang YB.. (2014) Synthesis and anti-BVDV activity of novel δ-sultones in vitro: implications for HCV therapies., 24 (10): [PMID:24745970] [10.1016/j.bmcl.2014.03.012] |
Source(1):